Restricting Fluoroquinolone Use Reduces Clostridium difficile Infection More Than Infection Control Methods.
Infection Control; Treatment Outcomes; Clostridium Difficile; Antiinfective Agents; Clostridium Infections – Drug Therapy; Fluoroquinolone – Administration and Dosage; Fluoroquinolone – Adverse Effects; Fluoroquinolone – Pharmacodynamics
An observational study from England showed that restricting fluoroquinolone use reduced incidence of Clostridium difficile infection more than would be predicted by improved infection control methods alone.
Watkins Richard R
Infectious Disease Alert
2017
2017-05
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
A new dosing paradigm: high-dose, short-course fluoroquinolone therapy for community-acquired pneumonia.
Antiinfective Agents; Fluoroquinolone; Pneumonia – Drug Therapy; Fluoroquinolone – Therapeutic Use; Fluoroquinolone – Administration and Dosage; Fluoroquinolone – Pharmacodynamics; Fluoroquinolone – Economics
The goals of optimal antimicrobial therapy are to treat infection effectively, to improve the clinical condition of the patient, and to prevent the emergence of resistant bacterial strains. For ideal drug usage the World Health Organization recommends administering the correct drug by the best route, in the right amount, at optimum intervals for the appropriate period, and after an accurate diagnosis. This article discusses the use of high-dose, short-course fluoroquinolone therapy as an effective option for patients with community-acquired pneumonia.
File T M Jr
Clinical Cornerstone
2003
2003-03-04
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1016/s1098-3597(03)90026-3" target="_blank" rel="noreferrer noopener">10.1016/s1098-3597(03)90026-3</a>